Benjamin P. Zuckerman
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
From paradox to biology: shared genetic architecture underlies the inverse association between smoking and Sjögren's disease.
Journal: Rheumatology (Oxford, England)
Published: April 01, 2026
Incidence of gout in spondyloarthritis.
Journal: Rheumatology advances in practice
Published: March 21, 2026
The role of interleukin-17 inhibition in systemic lupus erythematosus-paradoxical hindrance or new therapeutic potential? Results from a systematic literature review and mendelian randomization.
Journal: Frontiers in immunology
Published: September 16, 2025
Enteropathic arthritis is associated with an increased risk of major adverse cardiovascular events and venous thromboembolism.
Journal: Rheumatology advances in practice
Published: July 12, 2025
The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs.
Journal: Rheumatology (Oxford, England)
Published: May 08, 2025
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort study.
Journal: Rheumatology (Oxford, England)
Published: March 08, 2025
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' reply.
Journal: The Lancet. Rheumatology
Published: January 28, 2025
Abatacept and the risk of malignancy: a meta-analysis across disease indications.
Journal: Rheumatology (Oxford, England)
Published: November 07, 2024
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study.
Journal: Rheumatology (Oxford, England)
Published: August 14, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study.
Journal: The Lancet. Rheumatology
Published: March 15, 2024
Association between interleukin-12 p40 subunit and risk of primary Sjögren's disease: a Mendelian randomization study.
Journal: Rheumatology (Oxford, England)
Published: March 10, 2024
Last Updated: 09/26/2026